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1. Introduction
Gastroesophageal reflux disease (GERD) occurs frequently in developed 
countries. The number of cases, in fact, is increasing in the Middle East 
countries. In western countries, its occurrence ranges from 10 to 20% of the 
population who may present with typical or atypical symptoms or with com-
plications. Although GERD was described by Asher Winkelstein, an American 
gastroenterologist, in 1935, it had appeared among patients earlier than that 
time. Nowadays, cases of GERD are common among obese individuals, patients 
with gallbladder disease, and those individuals under stress. It has also become 
a common clinical problem that commonly affects young adults, both male and 
female, of 40 years old.
2. History of GERD
1855—Bowditch Rokitansky reported that esophagitis was due to gastroesopha-
geal reflux. Allison and Barrett found the association between hiatus hernia and 
gastroesophageal reflux.
1828—Charles Millard in Paris noticed the first case of esophagitis in child.
1879—Heinrich Quincke reported that ulceration in the esophagus was due to 
gastroesophageal reflux.
1906—Tilston described the typical symptoms of esophagitis.
1920—Joseph Sheehan described the endoscopic findings of esophagitis.
1921—Porter Vinson noted the association between stricture and esophagitis.
1934—Hampel introduced the term peptic esophagitis.
1956—Rudolf Nissen performed a successful fundoplication for patient, who 
suffered from GERD, with hiatus hernia. Patient was cured from the complaint.
3. Anatomy and Physiology
At the lower end of the esophagus is a sphincter which is formed by a change 
in the muscles of the esophagus. This sphincter controls the flow of esophageal 
contents to the stomach. Different factors related to the anatomy and physiology 
of the sphincter prevent the reflux of gastric contents into the esophagus. Among 
these factors include the following:
1. High pressure zone: Pressure at the lower esophageal sphincter area is high 
than stomach pressure (gastric pressure is +4 to +6, at the lower esophageal 
sphincter is +24 mmgh, and in the thoracic esophagus is −6). Because of the high 
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pressure at the sphincter, reflux is prevented. There are specific factors which 
will increase the tone of the sphincter, as well as factors like taking fatty meals, 
chocolate, smoking, and oral contraceptives that will reduce the tone of the 
sphincter.
2. The length of the lower esophageal sphincter is 3 cm which is divided into 
abdominal part and thoracic part. If the abdominal part is less than 2 cm, 
patient will get reflux. Other factors like change of mucosa, the muscular 
coat of the stomach which will have oblique muscles in addition to the other 
two types of circular and longitudinal, crural effect and angulation of the 
esophagus to the stomach which is called Angle of His are not important in the 
prevention of the gastroesophageal reflux.
3. Other factors that increase the effect of acid on the esophagus. Among these 
factors include the delayed gastric emptying. The increasing amount of the 
food in the stomach will lead to absorption of the sphincter and will increase 
the reflux. Reduced mucus and reduced saliva will lead to reduced bicarbonate 
which will reduce the effect of the acid refluxate.
4. Clinical presentation of gastroesophageal reflux disease
GERD appears with typical symptoms or rarely by atypical symptoms, which 
resemble cardiac symptoms and have been called cardiac symptoms.
4.1 Typical symptoms
Typical symptoms which appear among 70% of patients include the following:
1. Retrosternal pain (i.e., heart burn): It is the most common symptom which will 
be more manifested when patient is lying down or after meal and is seen among 
80% of patients.
2. Regurgitation: It is a symptom observed when gastric or esophageal content comes 
in the mouth effortlessly. Regurgitation of gastric content will reach tracheobron-
chial tree and will induce hoarseness of voice which is usually experienced in the 
morning. This hoarseness could be due to reflux of gastric content into the larynx 
or due to vagal irritation and will induce reflex spasm of the vocal cords. This 
symptom is seen among 50% of patients [1–6].
3. Dysphagia: This is observed among 20% of patients with gastroesophageal 
reflux disease.
Some rare presenting complaints, with rate of occurrence among patients, are as 
follows:
1. Abdominal pain: 30%
2. Belching: 30%
3. Coughing: 20%
4. Wheezing: 10%
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4.2 Atypical symptoms
Atypical symptoms are those where the patient will present with symptoms 
not related to gastrointestinal system: coughing, wheezing, recurrent pharyn-
gitis, laryngitis, and chest pain. Its acute onset may resemble acute myocardial 
infarction.
Patient may present with complicated gastroesophageal reflux disease—
some symptoms include the following: stricture, Barrett esophagus, lung damage in 
the form of pneumonia, and lung fibrosis if condition goes chronic.
5. Investigations
1. Upper gastrointestinal endoscopy: Upper gastrointestinal endoscopy is very 
important to exclude other serious disease which may mimic reflux, like tumors [7]. 
Upper gastrointestinal endoscopy can confirm hiatus hernia (Figure 1). Esophagitis 
will be experienced by 50% of patients with GERD. It can also diagnose Barrett 
esophagus and esophageal peptic stricture (Figure 2).
2. Contrast barium study: It is applied to detect hiatal hernia and esophageal 
stricture [8]. Barium contrast study can show hiatus hernia which can be small 
or large sac (Figures 3–5).
3. PH monitoring: 24 pH monitoring is very important in atypical presentation 
of gastroesophageal reflux disease [9, 10]. It can confirm or exclude the disease, 
with a diagnostic rate of 70–90%. It is not indicated in patients with esophagitis.
Figure 1. 
The use of upper gastrointestinal endoscopy showing hiatus hernia in patient with GERD.
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4. Gastroesophageal scintigraphy: Where drink like orange juice or milk is 
labeled with technetium and is used to study reflux, this test is rarely used 
for diagnosis of GERD. It is used in small children where we can study the 
reflexate to the lung, and the test is easy in small babies in comparison to 
other invasive tests. Gastroesophageal scintigraphy is used for patient who 
presents with atypical reflux symptoms like recurrent upper respiratory 
symptoms.
Figure 2. 
The use of upper gastrointestinal endoscopy showing peptic stricture.
Figure 3. 
Barium metal showing hiatus hernia.
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5. Multichannel impedance pH monitoring: It is a gold standard technique for 
diagnosis of GERD; it is more superior and more sensitive in diagnosing GERD 
than usual pH monitoring.
Figure 4. 
Barium metal showing child hiatus hernia.
Figure 5. 
Hiatus hernia with esophageal spasm.
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6. Manometry: It is a very important investigation to exclude motility disorders 
like achalasia and is indicated in patient who presents with atypical symptoms 
of gastroesophageal reflux disease. High-resolution manometry is more sensi-
tive and superior than ordinary manometry in diagnosing esophageal motility 
disorders.
6. Treatment
Reasons for treating GERD:
1. Heart burn is a troubling symptom and affects patient life.
2. Complications of GERD may cause esophagitis which will result to bleeding. 
Predisposition to Barrett esophagus that may turn to malignancy is 40–60 times 
seen in patient with reflux esophagitis-induced Barrett [11–13].
6.1 Nonsurgical treatment of gastroesophageal reflux disease
1. Change of lifestyle
a. Avoid having late meals, heavy meals, spicy or fatty meals, drinking alcohol, 
and smoking.
b. Reduce weight; avoid tight clothes around the waist.
c. Avoid drugs which reduce the tone of sphincter.
2. Medical
Medical treatment where drugs are used to neutralize the effect of the reflux on 
esophageal mucosa:
a. Antacids: Drugs that will neutralize the acid effect include the following—cal-
cium, aluminum, and magnesium compounds. These are best taken after meals. 
Their effect is brief; and once they get emptied from the stomach, the symptoms 
may come back. These need to be given on an hour base to neutralize the acid 
effect.
b. Histamine antagonists: There are receptors on the acid-producing cells which 
are stimulated by histamine to produce acid. These receptors are blocked by 
histamine-blocking drugs which act on H2 receptors. These drugs are best 
taken before meals. These include cimetidine which can be given 400–800 mg 
daily, ranitidine given 150 mg twice daily, and famotidine given 20–40 mg 
twice daily.
c. Proton-pump inhibitors: These include omeprazole, esomeprazole, lansoprazole, 
pantoprazole, and rabeprazole. Their dosages range from 20 to 40 mg daily. PPI 
will cure the esophagitis up to 90%; 80% will recur within 1 year if treatment is 
stopped [14–17].
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7. Surgery
Indication of surgery:
1. Failure of medical treatment.
2. Development of complications of the drugs.
3. Association with large hiatal hernia.
4. Atypical presentation with positive 24 h pH records.
5. Patients do not like to take drug for long life to control the symptoms.
7.1 Surgery for GERD
It can be done by lengthening the lower esophageal sphincter to create valve-like action 
to prevent refluxing of gastric contents in the esophagus. Procedure is done by wrapping 
the stomach around the lower esophagus [18–20], either full wrap of 360° (which is 
named after Nissen) or partial wrap of 270°, either done posteriorly or anteriorly.
Fundoplication was previously performed by open surgery. Nowadays, most 
operations are done laparoscopically (Figures 6 and 7), with excellent outcome on 
short-term and long-term follow-ups.
Patient will stop taking the drugs. All patients should be seen by gastroenterolo-
gist, ENT specialist, and surgeons before surgery, especially for those patients who 
come with atypical symptoms of GERD.
For many years, open surgery has been used for hiatus hernia but was rarely 
applied for GERD without hernia. Many operations can be done, either abdominal 
approach or thoracic approach. The common operation is the Nissen fundoplication 
which has been used since 1950, with a success rate of 80–90%. Its complication 
rate ranges from 10 to 15% and includes difficulty in swallowing and flatulence 
which may go for some time than ease off.
7.2 Endoluminal surgery (NOTES)
It is also called incisionless surgery. Endoscopic treatment of GERD is still under 
investigation:
1. Natural orifices transendoscopic surgery [21–25]
2. Endoscopic augmentation of lower esophageal sphincter, either by radio 
frequency application or injection of ethylene vinyl alcohol in the region of the 
lower esophageal sphincter [26–30].
7.3 Esophageal magnet ring
It is a new technique where there is no need to make wrapping around the 
lower esophagus by the stomach. This is a magnet ring fixed around the lower 
esophagus [31, 32]. It is not widely used and still under trial where magnet ring 
is fixed laparoscopically around the esophageal sphincter. It moves out once food 
comes in, and it comes back when the food enters the stomach. It has benefit 
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over Nissen fundoplication. The patient can belch, vomit, and have no gas bloat 
syndrome, and it is reversible. The technique, however, is still under long-term 
trials.
Figure 7. 
Laparoscopic view of hiatus hernia in patient came with GERD symptoms.
Figure 6. 
Laparoscopic view of big hiatus hernia in patient presented with GERD.
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